Long-term outcome of molecular subgroups of GIST patients treated with standard-dose imatinib in the BFR14 trial of the French Sarcoma Group

Autor: Patrikidou, Anna, Domont, Julien, Chabaud, Sylvie, Ray-Coquard, Isabelle, Coindre, Jean-Michel, Bui-Nguyen, Binh, Adenis, Antoine, Rios, Maria, Bertucci, François, Duffaud, Florence, Chevreau, Christine, Cupissol, Didier, Pérol, David, Emile, Jean-François, Blay, Jean-Yves, Le Cesne, Axel
Zdroj: In European Journal of Cancer January 2016 52:173-180
Databáze: ScienceDirect
Externí odkaz: